Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart disease.

Massey LK, Ward JL, Crooks AV, Guillot E, Ceron J, Rubio C, Convey V, Tropf M, Ciou MJ, Mochel JP, Oyama MA

DOI: 10.1093/jvimsj/aalag036
Published: 2026 Mar 2
Container: Journal of veterinary internal medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jvimsj/aalag036,
  title = {Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart disease.},
  author = {Massey LK and Ward JL and Crooks AV and Guillot E and Ceron J and Rubio C and Convey V and Tropf M and Ciou MJ and Mochel JP and Oyama MA},
  year = {2026},
  journal = {Journal of veterinary internal medicine},
  doi = {10.1093/jvimsj/aalag036},
  url = {https://doi.org/10.1093/jvimsj/aalag036}
}

RIS

TY  - JOUR
TI  - Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart disease.
AU  - Massey LK
AU  - Ward JL
AU  - Crooks AV
AU  - Guillot E
AU  - Ceron J
AU  - Rubio C
AU  - Convey V
AU  - Tropf M
AU  - Ciou MJ
AU  - Mochel JP
AU  - Oyama MA
PY  - 2026
JO  - Journal of veterinary internal medicine
DO  - 10.1093/jvimsj/aalag036
UR  - https://doi.org/10.1093/jvimsj/aalag036
ER  -

APA

LK, M., JL, W., AV, C., E, G., J, C., C, R., V, C., M, T., MJ, C., JP, M., & MA, O. (2026). Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart disease.. Journal of veterinary internal medicine. https://doi.org/10.1093/jvimsj/aalag036

Source records

pubmed · retrieved 2026-09-26T04:40:57.199Z